Page last updated: 2024-12-06

rhamnose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID25310
CHEBI ID62346
CHEBI ID26546
CHEBI ID62345
SCHEMBL ID713153
MeSH IDM0019003

Synonyms (47)

Synonym
deoxymannose
10485-94-6
mannose, 6-deoxy-
rhamnopyranose
l-mannopyranose, 6-deoxy-
l-rha
73-34-7
C00507
rhamnose ,
6-deoxy-l-mannose
l-rhamnose ,
alpha-l-rhamnose
l-rhamnopyranose ,
l-rhamnose monohydrate ,
l-(+)-rhamnose
(3r,4r,5r,6s)-6-methyloxane-2,3,4,5-tetrol
6-deoxy-dl-mannose
dl-rhamnose
dl-mannose, 6-deoxy-
CHEBI:62346 ,
6-deoxy-l-mannopyranose
EPITOPE ID:225177
AKOS017343737
SCHEMBL713153
RHA ,
6-deoxy-mannopyranose
6-deoxy-l-mannopyranoside
6-deoxy-mannopyranoside
6-deoxy-mannose
6-deoxy-l(+)-mannose
l-(+)-rhamnose hydrate = 6-deoxy-l-mannose monohydrate
p-(6-deoxy-b-l-mannopyranosyl) ester
mono(6-deoxy-b-l-mannopyranosyl) ester
mono(6-deoxy-beta-l-mannopyranosyl) ester
l-(+)-rhamnose 1-hydrate
uridine diphosphate rhamnose
l-rhamnose for biochemistry
p-(6-deoxy-beta-l-mannopyranosyl) ester
BS-10029
EN300-1697438
DTXSID801019197 ,
chebi:26546
ramnose
l-rhamnoses
chebi:62345
dtxcid501477194
dtxcid5022647

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"5 grams of the following (random order): Tm, rice (as reference atoxic protein) and Amygluten (as reference toxic protein) dispersed in a gluten-free pudding."( Search for atoxic cereals: a single blind, cross-over study on the safety of a single dose of Triticum monococcum, in patients with celiac disease.
Di Toro, N; Lanzarotto, F; Lanzini, A; Not, T; Petroboni, B; Pogna, N; Ricci, C; Villanacci, V; Zanini, B, 2013
)
0.39
" Adverse gastrointestinal events were 8 for Tm, Vs 11 for rice (p = 0."( Search for atoxic cereals: a single blind, cross-over study on the safety of a single dose of Triticum monococcum, in patients with celiac disease.
Di Toro, N; Lanzarotto, F; Lanzini, A; Not, T; Petroboni, B; Pogna, N; Ricci, C; Villanacci, V; Zanini, B, 2013
)
0.39
"No definite conclusion can be drawn on the safety of Tm, based on no change in urinary L/R because even Amygluten, a toxic wheat protein, did not cause a significant change in urinary L/R indicating low sensitivity of this methodology in studies on acute toxicity."( Search for atoxic cereals: a single blind, cross-over study on the safety of a single dose of Triticum monococcum, in patients with celiac disease.
Di Toro, N; Lanzarotto, F; Lanzini, A; Not, T; Petroboni, B; Pogna, N; Ricci, C; Villanacci, V; Zanini, B, 2013
)
0.39

Bioavailability

We measured the bioavailability and rates of absorption of two metabolically inert carbohydrates not transported by mediated pathways. The bioavailability of paracellular probes declined with increasing molecular mass (rhamnose, 62+/-4%) and was significantly higher in bats than has been reported for rats and other mammals.

ExcerptReferenceRelevance
"A microbial surfactant (biosurfactant) was investigated for its potential to enhance bioavailability and, hence, the biodegradation of octadecane."( Enhanced octadecane dispersion and biodegradation by a Pseudomonas rhamnolipid surfactant (biosurfactant).
Miller, RM; Zhang, Y, 1992
)
0.28
"To determine the effects of poorly absorbed solute on intestinal absorption, the urinary recovery of ingested lactulose, L-rhamnose, D-xylose, and 3-O-methyl-D-glucose was measured after simultaneous ingestion of various 'loads' of mannitol given in iso-osmolar solution."( The effect of poorly absorbed solute on intestinal absorption.
Catt, SD; Creamer, B; Heduan, E; Jenkins, AP; Menzies, IS; Segal, MB, 1990
)
0.28
"We have previously shown that small oral doses of poorly absorbed solute can significantly reduce absorption of test sugars in normal volunteers."( The effect of ingested lactulose on absorption of L-rhamnose, D-xylose, and 3-O-methyl-D-glucose in subjects with ileostomies.
Creamer, B; Jenkins, AP; Menzies, IS; Nukajam, WS, 1994
)
0.29
" We suggest that rhamnolipid production and attachment increased the bioavailability of phenanthrene, so promoting biodegradation activity."( Bioavailability of solid and non-aqueous phase liquid (NAPL)-dissolved phenanthrene to the biosurfactant-producing bacterium Pseudomonas aeruginosa 19SJ.
De Olmedo, E; García-Junco, M; Ortega-Calvo, JJ, 2001
)
0.31
" Bioavailability was calculated as F=AUC by gavage/AUC by injection, where AUC is the area under the curve of plasma probe concentration vs."( Intestinal passive absorption of water-soluble compounds by sparrows: effect of molecular size and luminal nutrients.
Caviedes-Vidal, E; Chediack, JG; Fasulo, V; Karasov, WH; Yamin, LJ, 2003
)
0.32
" We measured the bioavailability and rates of absorption of two metabolically inert carbohydrates not transported by mediated pathways (L-rhamnose and cellobiose, molecular masses of 164 and 342, respectively) to measure paracellular uptake, and of a non-metabolized D-glucose analog (3-O-methyl-D-glucose) to measure total uptake by both mediated and paracellular pathways."( Paracellular nutrient absorption in a gum-feeding new world primate, the common marmoset Callithrix jacchus.
Karasov, WH; McWhorter, TJ, 2007
)
0.34
" As predicted, the bioavailability of paracellular probes declined with increasing molecular mass (rhamnose, 62+/-4%; cellobiose, 22+/-4%) and was significantly higher in bats than has been reported for rats and other mammals."( Absorption of sugars in the Egyptian fruit bat (Rousettus aegyptiacus): a paradox explained.
Karasov, WH; Korine, C; McWhorter, TJ; Pinshow, B; Tracy, CR; Wojciechowski, MS, 2007
)
0.34
"Paclitaxel has problems with respect to bioavailability and resistance."( Enhancement of paclitaxel transport and cytotoxicity by 7,3',4'-trimethoxyflavone, a P-glycoprotein inhibitor.
Choi, CH; Jeong, JM, 2007
)
0.34
"These results indicate that TMF with low toxicity can be used as an enhancer of oral paclitaxel bioavailability and as a Pgp inhibitor."( Enhancement of paclitaxel transport and cytotoxicity by 7,3',4'-trimethoxyflavone, a P-glycoprotein inhibitor.
Choi, CH; Jeong, JM, 2007
)
0.34
" This system was used for fermentation of tomato pulp, with the aim of improving the bioavailability of flavonoids in processed tomato products."( Characterization of Rhamnosidases from Lactobacillus plantarum and Lactobacillus acidophilus.
Beekwilder, J; de Vos, R; Francke, C; Hall, RD; Janssen, P; Marcozzi, D; van Hylckama Vlieg, J; Vecchi, S, 2009
)
0.35
" When experiments aimed at increasing the oral bioavailability of hydrophilic compounds are performed, timing of fasting should be extremely accurate."( Fasting increases tobramycin oral absorption in mice.
De Leo, L; Decorti, G; Di Toro, N; Malusà, N; Not, T; Ventura, A, 2010
)
0.36
"Glycosylation is a key modification for most molecules including plant natural products, for example, flavonoids and isoflavonoids, and can enhance the bioactivity and bioavailability of the natural products."( Crystal structures of rhamnosyltransferase UGT89C1 from Arabidopsis thaliana reveal the molecular basis of sugar donor specificity for UDP-β-l-rhamnose and rhamnosylation mechanism.
Fei, S; Gao, Y; Li, J; Liu, X; Shen, Y; Wang, X; Yang, X; Zong, G, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" The dose-response effect of mannitol on the absorption of L-rhamnose was approximately exponential; doses of 5, 10, and 20 g mannitol reduced the average urinary excretion of L-rhamnose by 34."( The effect of poorly absorbed solute on intestinal absorption.
Catt, SD; Creamer, B; Heduan, E; Jenkins, AP; Menzies, IS; Segal, MB, 1990
)
0.28
" Urine was collected for 5 h, test sugar content being subsequently measured by thin-layer chromatography for the dosing sugars."( Intestinal permeability and function in patients infected with human immunodeficiency virus. A comparison with coeliac disease.
Johnson, MA; Lee, CA; Lim, SG; Menzies, IS; Pounder, RE, 1993
)
0.29
" The aim of this study was to determine whether a low dosage of lactulose is able to discriminate between normal and increased permeability."( The sensitivity of the lactulose/rhamnose gut permeability test.
Brouns, F; Brummer, RJ; Deutz, NE; Geerling, BJ; van Nieuwenhoven, MA, 1999
)
0.3
"05, dosage of 200 mg/kgd body weight) in peripheral lymphocytes compared to the irradiated control."( Water-soluble polysaccharides from Angelica sinensis (Oliv.) Diels: Preparation, characterization and bioactivity.
Gu, X; Li, D; Sun, Y; Tang, J, 2005
)
0.33
" The forms of these curves did not change significantly following dosing with aspirin."( Differential trafficking of saccharidic probes following aspirin in clinical tests of intestinal permeability in young healthy women.
Hurst, RD; Kruger, MC; Lentle, RG; Sequeira, IR, 2014
)
0.4
"To examine the dose-response effects of acute glutamine supplementation on markers of gastrointestinal (GI) permeability, damage and, secondary, subjective symptoms of GI discomfort in response to running in the heat."( Glutamine supplementation reduces markers of intestinal permeability during running in the heat in a dose-dependent manner.
Close, GL; Doran, DA; Fleming, SC; Highton, J; Hutson, M; Morton, JP; Pugh, JN; Sage, S, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
L-rhamnoseAny rhamnose having L-configuration. L-rhamnose occurs naturally in many plant glycosides and some gram-negative bacterial lipopolysaccharides.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
AtMetExpress overview0109

Research

Studies (1,921)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990725 (37.74)18.7374
1990's284 (14.78)18.2507
2000's368 (19.16)29.6817
2010's383 (19.94)24.3611
2020's161 (8.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials37 (1.86%)5.53%
Reviews41 (2.06%)6.00%
Case Studies3 (0.15%)4.05%
Observational1 (0.05%)0.25%
Other1,906 (95.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]